Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0K1R stock hub

LON/0K1R has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0K1Ris not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0K1R

In the news

Latest news · LON/0K1R

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-58.1

P25 -54.2P50 2.1P75 13.7

ROIC-36.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0K1R market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	252
Employees Change	109%
Employees Change Percent	76.22
Enterprise value	$833.2M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US92790C1045
Last refreshed	2026-05-10
Market cap	$1.3B
Price	$16.66
Price currency	USD
Rev Per Employee	213,121.25x
Sector	Healthcare
Sic	2836
Symbol	lon/0K1R
Website	https://www.viridiantherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-18.28%
EV Earnings	-3.63x
EV/FCF	-3.62x
EV/Sales	16.01x
FCF yield	-18.31%
P/B ratio	2.61x
P/S ratio	23.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-203.5M
Net Income	$-229.7M
Net Income Growth Years	0%
Pretax Margin	-508.46%
Profit Per Employee	$-911,371
ROA	-33.25
Roa5y	-29.68
ROCE	-52.32
ROE	-58.14
Roe5y	-50.12
ROIC	-36.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	35.48%
Cagr3y	-15.56%
Cagr5y	-9.68%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	23,382.78x
Revenue Growth Q	95.83x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	250x
Revenue Growth5 Y	111.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.1
Assets	$597.5M
Cash	$577.2M
Current Assets	$575.6M
Current Liabilities	$38M
Debt	$40.4M
Debt Equity	$0.08
Debt FCF	$-0.18
Equity	$481.7M
Interest Coverage	-49.07
Liabilities	$115.9M
Long Term Assets	$21.9M
Long Term Liabilities	$77.9M
Net Cash	$536.8M
Net Cash By Market Cap	$42.72
Net Cash Growth	15.53%
Net Debt Equity	$-1.11
Tangible Book Value	$381.6M
Tangible Book Value Per Share	$3.72
WACC	8.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.15
Net Working Capital	$-21.6M
Quick ratio	14.71
Working Capital	$555.1M
Working Capital Turnover	$0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-23.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	35.45%
200-day SMA	24.25
3Y total return	-39.79%
50-day SMA	21.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-39.9%
All Time High	38.51
All Time High Change	-56.74%
All Time High Date	2023-01-25
All Time Low	9.15
All Time Low Change	82.08%
All Time Low Date	2020-05-07
ATR	1.6
Beta	0.82
Ch YTD	-46.48
High	17.23
High52	34.31
High52 Date	2026-01-15
High52ch	-51.44%
Low	16.43
Low52	12.02
Low52 Date	2025-05-08
Low52ch	41.55%
Ma50ch	-21.35%
Price vs 200-day SMA	-31.29%
RSI	49.35
RSI Monthly	46.05
RSI Weekly	36.37
Sharpe ratio	0.62x
Sortino ratio	0.94
Total Return	-23.41%
Tr YTD	-46.48
Tr1m	17.66%
Tr1w	25.26%
Tr3m	-42.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-292.1M
Operating margin	-543.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,599,026%
Net Borrowing	21,180,216.8
Shares Insiders	0.06%
Shares Institutions	100.85%
Shares Qo Q	8.3%
Shares Yo Y	23.41%
Short Ratio	4.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-266M
Average Volume	8,312.3x
Bv Per Share	3.72
CAPEX	$-327,156
Ch1m	17.66
Ch1w	25.26
Ch1y	35.45
Ch3m	-42.89
Ch3y	-39.79
Ch5y	-39.9
Ch6m	-37.31
Change	-2.26%
Change From Open	-1.71
Close	17.05
Days Gap	-0.59
Depreciation Amortization	340,350.5
Dollar Volume	72,937.5
Earnings Date	2026-08-07
EBIT	$-292.1M
EBITDA	$-291.7M
EPS	$-2.55
F Score	1
FCF	$-230.1M
FCF EV Yield	-27.62x
Financing CF	321,011,745
Fiscal Year End	December
Founded	2,010
Investing CF	-45,713,959
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2026-03-31
Last Split Date	2020-11-13
Last Split Type	Reverse
Ma150	26.18
Ma150ch	-36.37%
Ma20	14.85
Ma20ch	12.21%
Net CF	45,537,507
Next Earnings Date	2026-08-07
Open	16.95
Position In Range	28.75
Ppne	2,482,944.9
Price Date	2026-05-08
Ptbv Ratio	3.29
Relative Volume	0.54x
Revenue	53,706,556x
SBC By Revenue	66.94x
Share Based Comp	35,951,540
Tr6m	-37.31%
Volume	4,378
Z Score	4.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0K1R pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0K1R stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0K1R?

Insider, institutional, and short-interest positioning.

Institutional ownership

+100.9%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0K1R momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.4

Neutral momentum band

Price vs 200-day MA

-31.3%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0K1R

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0K1R stock rating?

lon/0K1R is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0K1R analysis?

The full report lives at /stocks/lon/0K1R/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0K1R?

The latest report frames lon/0K1R around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0K1R page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.